Bleakley Financial Group »

Terns Pharmaceuticals shares owned by Bleakley Financial Group

Quarter-by-quarter ownership of Terns Pharmaceuticals (TERN) shares owned by Bleakley Financial Group from 13F filings

Historical chart of Bleakley Financial Group investment in Terns Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Terns Pharmaceuticals held by Bleakley Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Terns Pharmaceuticals by Bleakley Financial Group

Quarter filed Position value Share count Share price at filing
2024-09-30 $111k 13k 8.34
2024-06-30 $72k 11k 6.81
2023-12-31 $68k 11k 6.49

More positions owned by Bleakley Financial Group

Vanguard Index Fds Large Cap Etf (VV)
Apple (AAPL)
Sprott Physical Gold & Silve Tr Unit (CEF)
Vanguard Index Fds Mid Cap Etf (VO)
Vanguard Index Fds Value Etf (VTV)
Microsoft Corporation (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Mun Bd Fds Tax Exempt Bd (VTEB)
NVIDIA Corporation (NVDA)
Sprott Physical Gold Tr Unit (PHYS)
Ishares Tr 0-3 Mnth Treasry (SGOV)
Vanguard Intl Equity Index F Tt Wrld St Etf (VT)
Amazon (AMZN)
Ishares Tr 1 3 Yr Treas Bd (SHY)
Vanguard Malvern Fds Strm Infproidx (VTIP)

View all positions for Bleakley Financial Group

Top funds holding Terns Pharmaceuticals

OrbiMed Advisors
Deep Track Capital
Soleus Capital Management
BlackRock
BlackRock
Citadel Advisors
VR Adviser
Schonfeld Strategic Advisors
Point72 Asset Management
Vanguard Group
Avidity Partners Management
Driehaus Capital Management
ExodusPoint Capital Management
T. Rowe Price Associates
Geode Capital Management

View all funds holding Terns Pharmaceuticals